Skip to main content

BMS-354825 (Dasatinib) | Abl/Src inhibitor

$79.00
SKU:
C2354-10
Bulk Pricing:
Buy in bulk and save
Adding to cart… The item has been added

Dasatinib is an orally-available, aminothiazole-based inhibitor of Abl and Src at IC50 values of 0.6 and 8 nm, respectively. [1] Dasatinib has been shown to be >300-fold more potent than imatinib in cells expressing wild-type Bcr-Abl and in a number of imatinib-resistant mutants at IC50s < 1.7 nM. [2] With the exception of T315I, Dasatinib inhibited cell proliferation of mutants in the range of 0.8 to 11 nM.

Dasatinib's activity against Lck allows for inhibition of T-cell receptor-mediated signal transduction, cellular proflieration, cytokine production, and in vivo T-cell responses. Combination of dasatinib with other immunomodulators such as cyclosporine A or rapamycin results in a synergistic inhibition of T-cell activation. [3]


Technical information:

Chemical Formula:   C22H26ClN7O2S
CAS #:   302962-49-8, 863127-77-9
Molecular Weight:   488.01
Purity:   > 99%
Appearance:   White Crystalline
Chemical Name:   N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide
Solubility:   Up to 100 mM in DMSO
Synonyms:   BMS-354825, BMS 354825, BMS354825, Sprycel, dasatinibum, Dasatinib

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.


Reference:

1. O'Hare et al., In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Res. 2005, 65, 4500-4505. Pubmed ID: 15930265
2. Steinberg et al., Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Clin. Ther. 2007, 29(11), 2289-2308. Pubmed ID: 18158072
3. Schade et al., Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation. Blood, 2008, 111, 1366-1377. Pubmed ID: 17962511

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.